Iulia Făgărășan

ORCID: 0000-0003-3718-8556
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Viral gastroenteritis research and epidemiology
  • Diabetes and associated disorders
  • SARS-CoV-2 and COVID-19 Research
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • COVID-19 and healthcare impacts
  • Diabetes Management and Research
  • Pancreatitis Pathology and Treatment

Iuliu Hațieganu University of Medicine and Pharmacy
2022-2024

Inflammation along with coagulation disturbances has an essential role in the evolution towards a severe disease patients coronavirus 2019 (COVID-19). This study aimed to evaluate inflammatory and biomarkers when predicting need visit intensive care unit (ICU) diabetes mellitus (DM) patients. In retrospective study, laboratory parameters were examined for 366 participants: ICU = 90, of which 44 had DM no admittance 276. The ability markers distinguish severity COVID-19 was determined using...

10.3390/ijms241914908 article EN International Journal of Molecular Sciences 2023-10-05

Background: As the global battle against COVID-19 pandemic endures, spread of Delta variant has introduced nuanced challenges, prompting a examination. Materials and Methods: We performed multilevel logistic regression analysis encompassing 197 patients, comprising 44 vaccinated individuals (V group) 153 unvaccinated counterparts (UV). These afflicted with SARS-CoV-2, were hospitalized between October 2021 February 2022 at department University Centre in Cluj-Napoca, Romania. compared...

10.3390/jpm14040358 article EN Journal of Personalized Medicine 2024-03-28

Some studies have reported that chronic respiratory illnesses in patients with COVID-19 result an increase hospitalization and death rates, while other to the contrary. The present research aims determine if a predictive model (developed by combing different clinical, imaging, or blood markers) could be established for both obstructive pulmonary disease (COPD) COVID-19, order able foresee outcomes of these patients. A prospective observational cohort 165 diseases was analyzed terms clinical...

10.3390/diagnostics13152597 article EN cc-by Diagnostics 2023-08-04

The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is one of world’s most disruptive health crises. presence diabetes plays an important role in severity infection, and a rise newly diagnosed cases has been identified. aim this retrospective study was to determine incidence new-onset (NOD) predictive factors with their cut-off values for patients hospitalized COVID-19. All (n = 219) COVID-19 during three consecutive months were included. NOD...

10.3390/ijerph192013230 article EN International Journal of Environmental Research and Public Health 2022-10-14

Bakground: The mortality rate from community-acquired pneumonia (CAP) or coronavirus disease 19 (COVID-19) is high, especially in hospitalized patients. This study aimed to assess the disturbances of glucose and lipid metabolism with in-hospital complications short-term outcomes for patients different etiologies. Methods: observational comprised 398 divided as follows: 155 severe acute respiratory syndrome 2 (SARS-CoV-2) pneumonia, 129 participants viral CAP, 114 bacterial pneumonia....

10.3390/jcm13247832 article EN Journal of Clinical Medicine 2024-12-22
Coming Soon ...